71
Participants
Start Date
October 2, 2018
Primary Completion Date
August 7, 2020
Study Completion Date
August 7, 2020
ELX/TEZ/IVA
Fixed-dose combination tablet orally once daily in the morning.
IVA
IVA tablet orally once daily in the evening.
Northwell Health- Long Island Jewish Medical Center, New Hyde Park
Clinical Research of Charlotte, Charlotte
Nationwide Children's Hospital, Columbus
Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center, Cleveland
Children's Respiratory and Critical Care Specialists, P.A., Children's Hospitals and Clinics of Minnesota, Minneapolis
Ann & Robert Lurie Children's Hospital of Chicago, Chicago
The Children's Mercy Hospital, Kansas City
Texas Children's Hospital, Houston
Children's Hospital Colorado, Aurora
Children's Hospital of Orange County, Orange
Oregon Health & Science University, Portland
Seattle Children's Hospital, Seattle
Boston Children's Hospital, Boston
Queensland Children's Hospital, South Brisbane
The Children's Hospital at Westmead, Westmead
The Hospital for Sick Children, Toronto
British Columbia's Children's Hospital, Vancouver
Children's Health Ireland at Crumlin, Dublin
Children's Health Ireland at Temple Street, Dublin
Birmingham Children's Hospital, Birmingham
Royal Brompton & Harefield NHS Foundation Trust, Royal Brompton Hospital, London
Vertex Pharmaceuticals Incorporated
INDUSTRY